Treos Bio Ltd
- Biotech or pharma, therapeutic R&D
Treos Bio Ltd is a UK based biotech with a revolutionary method for cancer specific immunogenicity therapy with validation of the mechanism of action and of clinical promise in Colorectal Cancer. We are in the midst of seeking a limited Series B financing of $10-15M in order to complete a 140 patient Phase 2B study to get information critical to the design of a later Phase III registration program. This should be a significant value incrementation step.